Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 48 ($0.62) and last traded at GBX 48 ($0.62), with a volume of 11 shares changing hands. The stock had previously closed at GBX 49.50 ($0.64).
Arecor Therapeutics Stock Down 3.0 %
The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The stock has a market cap of £18.12 million, a price-to-earnings ratio of -1.70 and a beta of -0.18. The firm’s 50-day moving average is GBX 54.75 and its 200 day moving average is GBX 66.62.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- CD Calculator: Certificate of Deposit Calculator
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
